Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma

被引：0
|
作者：
C. Bueno Muiño
J. Puente Vázquez
J. Sastre Valera
J. A. García-Sáenz
M. Martín
N. García Miralles
A. Sánchez-Pernaute
E. Díaz-Rubio
机构：
[1] Hospital Clínico San Carlos,Servicio de Oncología Médica
[2] Hospital Clínico San Carlos,Servicio de Anatomía Patológica
[3] Hospital Clínico San Carlos,Servicio de Cirugía General
来源：
Clinical and Translational Oncology | 2007年 / 9卷
关键词：
Gastric cancer; Neoadjuvant chemotherapy; Docetaxel;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Locally advanced gastric adenocarcinoma has a poor outcome. Neoadjuvant treatment is being tested in locally advanced non-resectable tumours and in those resectable tumours with a high risk of recurrence. Efforts to identify prognostic factors and more active and less toxic preoperative regimens are being searched for. We report the case of a patient achieving a complete histopathological complete response following docetaxel-based neoadjuvant chemotherapy.
引用
收藏
页码：335 / 338
页数：3
相关论文
共 50 条
  • [1] Pathological complete response following docetaxel-based neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma
    Muino, C. Bueno
    Vazquez, J. Puente
    Valera, J. Sastre
    Garcia-Saenz, J. A.
    Martin, M.
    Miralles, N. Garcia
    Sanchez-Pernaute, A.
    Diaz-Rubio, E.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (05): : 335 - 338
  • [2] Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer
    Roberto Biffi
    Nicola Fazio
    Fabrizio Luca
    Antonio Chiappa
    Bruno Andreoni
    Maria Giulia Zampino
    Arnaud Roth
    Jan Christian Schuller
    Giancarla Fiori
    Franco Orsi
    Guido Bonomo
    Cristiano Crosta
    Olivier Huber
    World Journal of Gastroenterology, 2010, 16 (07) : 868 - 874
  • [3] Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer
    Biffi, Roberto
    Fazio, Nicola
    Luca, Fabrizio
    Chiappa, Antonio
    Andreoni, Bruno
    Zampino, Maria Giulia
    Roth, Arnaud
    Schuller, Jan Christian
    Fiori, Giancarla
    Orsi, Franco
    Bonomo, Guido
    Crosta, Cristiano
    Huber, Olivier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (07) : 868 - 874
  • [4] Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
    Shimamaki, Yoshitaka
    Hosokawa, Isamu
    Takayashiki, Tsukasa
    Takano, Shigetsugu
    Sonoda, Itaru
    Ohtsuka, Masayuki
    SURGICAL CASE REPORTS, 2024, 10 (01)
  • [5] Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
    Yoshitaka Shimamaki
    Isamu Hosokawa
    Tsukasa Takayashiki
    Shigetsugu Takano
    Itaru Sonoda
    Masayuki Ohtsuka
    Surgical Case Reports, 10
  • [6] Complete Pathological Response to Neoadjuvant Chemotherapy in EBV Positive Gastric Adenocarcinoma
    Taylor, J. L.
    Spence, D.
    Kennedy, R.
    Napier, E.
    Turkington, R.
    Eatock, M.
    Clements, W. D. B.
    McManus, D. T.
    JOURNAL OF PATHOLOGY, 2017, 243 : S30 - S30
  • [7] Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
    Hu, Qing
    Wang, Jian
    Xu, Wei-Guo
    Shao, Peng
    Li, Gang
    PRECISION MEDICAL SCIENCES, 2021, 10 (02): : 78 - 82
  • [8] A silver lining in the dark COVID cloud: Total neoadjuvant chemotherapy results in complete pathological response in locally advanced distal gastric adenocarcinoma
    Clements, Hollie Alice
    Patil, Pradeep
    Ramkumar, Prasad Guntur
    Walsh, Shaun
    Petty, Russell
    BRITISH JOURNAL OF SURGERY, 2021, 108
  • [9] Does histology dictate outcomes of locally advanced rectal adenocarcinoma with complete pathological response following neoadjuvant chemoradiation?
    Shinde, Rajesh S.
    Bhamre, Rahul
    Niyogi, Devayani
    Mitra, Abhishek
    Desouza, Ashwin
    Ostwal, Vikas
    Engineer, Reena
    Dusane, Rohit
    Saklani, Avanish
    JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (01) : 85 - 89
  • [10] RPN2 predicts response to the combination of docetaxel-based neoadjuvant chemotherapy (NAC) in advanced gastric cancer.
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    CANCER SCIENCE, 2018, 109 : 898 - 898
12345